Cargando…
Multifactorial Optimizations for Directing Endothelial Fate from Stem Cells
Embryonic stem cells (ESC) and induced pluripotent stem (iPS) cells are attractive in vitro models of vascular development, therapeutic angiogenesis, and tissue engineering. However, distinct ESC and iPS cell lines respond differentially to the same microenvironmental factors. Developing improved/op...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5131944/ https://www.ncbi.nlm.nih.gov/pubmed/27907001 http://dx.doi.org/10.1371/journal.pone.0166663 |
_version_ | 1782470969596575744 |
---|---|
author | Glaser, Drew E. Turner, William S. Madfis, Nicole Wong, Lian Zamora, Jose White, Nicholas Reyes, Samuel Burns, Andrew B. Gopinathan, Ajay McCloskey, Kara E. |
author_facet | Glaser, Drew E. Turner, William S. Madfis, Nicole Wong, Lian Zamora, Jose White, Nicholas Reyes, Samuel Burns, Andrew B. Gopinathan, Ajay McCloskey, Kara E. |
author_sort | Glaser, Drew E. |
collection | PubMed |
description | Embryonic stem cells (ESC) and induced pluripotent stem (iPS) cells are attractive in vitro models of vascular development, therapeutic angiogenesis, and tissue engineering. However, distinct ESC and iPS cell lines respond differentially to the same microenvironmental factors. Developing improved/optimized differentiation methodologies tailored/applicable in a number of distinct iPS and ESC lines remains a challenge in the field. Currently published methods for deriving endothelial cells (EC) robustly generate high numbers of endothlelial progenitor cells (EPC) within a week, but their maturation to definitive EC is much more difficult, taking up to 2 months and requiring additional purification. Therefore, we set out to examine combinations/levels of putative EC induction factors—utilizing our stage-specific chemically-defined derivation methodology in 4 ESC lines including: kinetics, cell seeding density, matrix signaling, as well as medium treatment with vascular endothelial growth factor (VEGF), and basic fibroblast growth factor (bFGF). The results indicate that temporal development in both early and late stages is the most significant factor generating the desired cells. The generation of early Flk-1(+)/KDR(+) vascular progenitor cells (VPC) from pluripotent ESC is directed predominantly by high cell seeding density and matrix signaling from fibronectin, while VEGF supplementation was NOT statistically significant in more than one cell line, especially with fibronectin matrix which sequesters autocrine VEGF production by the differentiating stem cells. Although some groups have shown that the GSK3-kinase inhibitor (CHIR) can facilitate EPC fate, it hindered the generation of KDR+ cells in our preoptimized medium formulations. The methods summarized here significantly increased the production of mature vascular endothelial (VE)-cadherin+ EC, with up to 93% and 57% purity from mouse and human ESC, respectively, before VE-cadherin+ EC purification. |
format | Online Article Text |
id | pubmed-5131944 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-51319442016-12-21 Multifactorial Optimizations for Directing Endothelial Fate from Stem Cells Glaser, Drew E. Turner, William S. Madfis, Nicole Wong, Lian Zamora, Jose White, Nicholas Reyes, Samuel Burns, Andrew B. Gopinathan, Ajay McCloskey, Kara E. PLoS One Research Article Embryonic stem cells (ESC) and induced pluripotent stem (iPS) cells are attractive in vitro models of vascular development, therapeutic angiogenesis, and tissue engineering. However, distinct ESC and iPS cell lines respond differentially to the same microenvironmental factors. Developing improved/optimized differentiation methodologies tailored/applicable in a number of distinct iPS and ESC lines remains a challenge in the field. Currently published methods for deriving endothelial cells (EC) robustly generate high numbers of endothlelial progenitor cells (EPC) within a week, but their maturation to definitive EC is much more difficult, taking up to 2 months and requiring additional purification. Therefore, we set out to examine combinations/levels of putative EC induction factors—utilizing our stage-specific chemically-defined derivation methodology in 4 ESC lines including: kinetics, cell seeding density, matrix signaling, as well as medium treatment with vascular endothelial growth factor (VEGF), and basic fibroblast growth factor (bFGF). The results indicate that temporal development in both early and late stages is the most significant factor generating the desired cells. The generation of early Flk-1(+)/KDR(+) vascular progenitor cells (VPC) from pluripotent ESC is directed predominantly by high cell seeding density and matrix signaling from fibronectin, while VEGF supplementation was NOT statistically significant in more than one cell line, especially with fibronectin matrix which sequesters autocrine VEGF production by the differentiating stem cells. Although some groups have shown that the GSK3-kinase inhibitor (CHIR) can facilitate EPC fate, it hindered the generation of KDR+ cells in our preoptimized medium formulations. The methods summarized here significantly increased the production of mature vascular endothelial (VE)-cadherin+ EC, with up to 93% and 57% purity from mouse and human ESC, respectively, before VE-cadherin+ EC purification. Public Library of Science 2016-12-01 /pmc/articles/PMC5131944/ /pubmed/27907001 http://dx.doi.org/10.1371/journal.pone.0166663 Text en © 2016 Glaser et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Glaser, Drew E. Turner, William S. Madfis, Nicole Wong, Lian Zamora, Jose White, Nicholas Reyes, Samuel Burns, Andrew B. Gopinathan, Ajay McCloskey, Kara E. Multifactorial Optimizations for Directing Endothelial Fate from Stem Cells |
title | Multifactorial Optimizations for Directing Endothelial Fate from Stem Cells |
title_full | Multifactorial Optimizations for Directing Endothelial Fate from Stem Cells |
title_fullStr | Multifactorial Optimizations for Directing Endothelial Fate from Stem Cells |
title_full_unstemmed | Multifactorial Optimizations for Directing Endothelial Fate from Stem Cells |
title_short | Multifactorial Optimizations for Directing Endothelial Fate from Stem Cells |
title_sort | multifactorial optimizations for directing endothelial fate from stem cells |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5131944/ https://www.ncbi.nlm.nih.gov/pubmed/27907001 http://dx.doi.org/10.1371/journal.pone.0166663 |
work_keys_str_mv | AT glaserdrewe multifactorialoptimizationsfordirectingendothelialfatefromstemcells AT turnerwilliams multifactorialoptimizationsfordirectingendothelialfatefromstemcells AT madfisnicole multifactorialoptimizationsfordirectingendothelialfatefromstemcells AT wonglian multifactorialoptimizationsfordirectingendothelialfatefromstemcells AT zamorajose multifactorialoptimizationsfordirectingendothelialfatefromstemcells AT whitenicholas multifactorialoptimizationsfordirectingendothelialfatefromstemcells AT reyessamuel multifactorialoptimizationsfordirectingendothelialfatefromstemcells AT burnsandrewb multifactorialoptimizationsfordirectingendothelialfatefromstemcells AT gopinathanajay multifactorialoptimizationsfordirectingendothelialfatefromstemcells AT mccloskeykarae multifactorialoptimizationsfordirectingendothelialfatefromstemcells |